497 related articles for article (PubMed ID: 18846023)
1. Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism.
La Vignera S; Calogero AE; D'Agata R; Di Mauro M; Tumino S; Condorelli R; Lanzafame F; Finocchiaro C; Giammusso B; Vicari E
Minerva Endocrinol; 2008 Sep; 33(3):159-67. PubMed ID: 18846023
[TBL] [Abstract][Full Text] [Related]
2. Hypogonadism and metabolic syndrome: implications for testosterone therapy.
Makhsida N; Shah J; Yan G; Fisch H; Shabsigh R
J Urol; 2005 Sep; 174(3):827-34. PubMed ID: 16093964
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study.
Aversa A; Bruzziches R; Francomano D; Greco EA; Fornari R; Di Luigi L; Lenzi A; Migliaccio S
Aging Male; 2012 Jun; 15(2):96-102. PubMed ID: 22439807
[TBL] [Abstract][Full Text] [Related]
4. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
Lunenfeld B; Saad F; Hoesl CE
Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
[TBL] [Abstract][Full Text] [Related]
5. Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.
Turchi P; Simi S; Pescatori ES
J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):61-8. PubMed ID: 16760628
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
7. Testosterone replacement therapy in obese males.
Drewa T; Olszewska-Słonina D; Chlosta P
Acta Pol Pharm; 2011; 68(5):623-7. PubMed ID: 21928705
[TBL] [Abstract][Full Text] [Related]
8. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
Mäkinen JI; Huhtaniemi I
Gerontology; 2011; 57(3):193-202. PubMed ID: 20689266
[TBL] [Abstract][Full Text] [Related]
9. The relationship between sex hormones and the metabolic syndrome.
Lunenfeld B
Acta Biomed; 2010; 81 Suppl 1():79-84. PubMed ID: 20518195
[TBL] [Abstract][Full Text] [Related]
10. Investigation, treatment and monitoring of late-onset hypogonadism in males.
Nieschlag E; Swerdloff R; Behre HM; Gooren LJ; Kaufman JM; Legros JJ; Lunenfeld B; Morley JE; Schulman C; Wang C; Weidner W; Wu FC
Aging Male; 2005 Jun; 8(2):56-8. PubMed ID: 16096159
[No Abstract] [Full Text] [Related]
11. Is discontinuation of hormone replacement therapy possible for patients with late-onset hypogonadism?
Tsujimura A; Takada S; Matsuoka Y; Hirai T; Takao T; Miyagawa Y; Nonomura N; Okuyama A
Int J Urol; 2008 Jul; 15(7):625-9. PubMed ID: 18479356
[TBL] [Abstract][Full Text] [Related]
12. Testosterone deficiency.
Traish AM; Miner MM; Morgentaler A; Zitzmann M
Am J Med; 2011 Jul; 124(7):578-87. PubMed ID: 21683825
[TBL] [Abstract][Full Text] [Related]
13. Testosterone replacement therapy for late-onset hypogonadism.
Cunningham GR
Nat Clin Pract Urol; 2006 May; 3(5):260-7. PubMed ID: 16691239
[TBL] [Abstract][Full Text] [Related]
14. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
Miner M; Canty DJ; Shabsigh R
Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin and testosterone in patients with symptoms of late-onset hypogonadism: is there a link?
Tsujimura A; Takada S; Matsuoka Y; Nakayama J; Takao T; Miyagawa Y; Sonoda M; Nishizawa H; Iwahashi H; Funahashi T; Nonomura N; Okuyama A
Int J Urol; 2009 Oct; 16(10):830-5. PubMed ID: 19719531
[TBL] [Abstract][Full Text] [Related]
16. Original immunophenotype of blood endothelial progenitor cells and microparticles in patients with isolated arterial erectile dysfunction and late onset hypogonadism: effects of androgen replacement therapy.
La Vignera S; Condorelli R; Vicari E; D'Agata R; Calogero A
Aging Male; 2011 Sep; 14(3):183-9. PubMed ID: 21271942
[TBL] [Abstract][Full Text] [Related]
17. [The efficacy of testosterone ointment (Glowmin) treatment for late-onset-hypogonadism (LOH) patients according to LOH severity].
Amano T; Imao T; Takemae K; Iwamoto T; Baba K; Yamakawa K; Nakazawa R; Yoshida K; Sugimori H; Tanaka T; Katabami T; Tanaka M
Hinyokika Kiyo; 2007 Jan; 53(1):25-9; discussion 29. PubMed ID: 17310765
[TBL] [Abstract][Full Text] [Related]
18. Testosterone replacement in men.
Beg S; Al-Khoury L; Cunningham GR
Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
[TBL] [Abstract][Full Text] [Related]
19. The emerging link between hypogonadism and metabolic syndrome.
Guay AT
J Androl; 2009; 30(4):370-6. PubMed ID: 18772486
[TBL] [Abstract][Full Text] [Related]
20. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
Miner MM; Seftel AD
Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]